Ono A, Miura R, Hayes CN, Kawaoka T, et al. Reply to "IL-6 as a biomarker in atezolizumab plus bevacizumab in patients with hepatocellular carcinoma". J Gastroenterol 2026 Mar 25. doi: 10.1007/s00535-026-02390.
PMID: 41879987